vs
Side-by-side financial comparison of HA Sustainable Infrastructure Capital, Inc. (HASI) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $114.8M, roughly 1.4× HA Sustainable Infrastructure Capital, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -46.8%, a 118.0% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 13.3%).
HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
HASI vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.8M | $158.6M |
| Net Profit | $-53.8M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | -57.4% | 70.2% |
| Net Margin | -46.8% | 71.2% |
| Revenue YoY | 13.3% | 3661.1% |
| Net Profit YoY | -176.7% | 528.0% |
| EPS (diluted) | $-0.38 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.8M | — | ||
| Q3 25 | $103.1M | — | ||
| Q2 25 | $85.7M | — | ||
| Q1 25 | $96.9M | $158.6M | ||
| Q4 24 | $101.3M | $22.6M | ||
| Q3 24 | $82.0M | — | ||
| Q2 24 | $94.5M | — | ||
| Q1 24 | $105.8M | — |
| Q4 25 | $-53.8M | — | ||
| Q3 25 | $83.3M | — | ||
| Q2 25 | $98.4M | — | ||
| Q1 25 | $56.6M | $112.9M | ||
| Q4 24 | $70.1M | $-10.5M | ||
| Q3 24 | $-19.6M | — | ||
| Q2 24 | $26.5M | — | ||
| Q1 24 | $123.0M | — |
| Q4 25 | -57.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 84.7% | 70.2% | ||
| Q4 24 | 90.9% | -60.4% | ||
| Q3 24 | -32.1% | — | ||
| Q2 24 | 39.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | -46.8% | — | ||
| Q3 25 | 80.8% | — | ||
| Q2 25 | 114.9% | — | ||
| Q1 25 | 58.4% | 71.2% | ||
| Q4 24 | 69.2% | -46.4% | ||
| Q3 24 | -23.9% | — | ||
| Q2 24 | 28.1% | — | ||
| Q1 24 | 116.3% | — |
| Q4 25 | $-0.38 | — | ||
| Q3 25 | $0.61 | — | ||
| Q2 25 | $0.74 | — | ||
| Q1 25 | $0.44 | $1.90 | ||
| Q4 24 | $0.58 | $-0.15 | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $0.23 | — | ||
| Q1 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $110.2M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $350.1M |
| Total Assets | $8.2B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $110.2M | — | ||
| Q3 25 | $301.8M | — | ||
| Q2 25 | $86.5M | — | ||
| Q1 25 | $67.4M | $274.8M | ||
| Q4 24 | $129.8M | $128.0M | ||
| Q3 24 | $44.1M | — | ||
| Q2 24 | $145.7M | — | ||
| Q1 24 | $61.4M | — |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.5B | $350.1M | ||
| Q4 24 | $2.4B | $229.0M | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.3B | — |
| Q4 25 | $8.2B | — | ||
| Q3 25 | $8.2B | — | ||
| Q2 25 | $7.6B | — | ||
| Q1 25 | $7.5B | $406.9M | ||
| Q4 24 | $7.1B | $271.6M | ||
| Q3 24 | $6.7B | — | ||
| Q2 24 | $6.7B | — | ||
| Q1 24 | $6.7B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.3M | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | — | ||
| Q3 25 | $-121.8M | — | ||
| Q2 25 | $79.6M | — | ||
| Q1 25 | $-37.1M | $131.8M | ||
| Q4 24 | $5.9M | $-23.2M | ||
| Q3 24 | $21.9M | — | ||
| Q2 24 | $-24.8M | — | ||
| Q1 24 | $20.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -1.46× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | -0.66× | 1.17× | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.94× | — | ||
| Q1 24 | 0.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
